Cargando…

Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti

BACKGROUND: The seroprevalence of hepatitis C varies substantially between countries and geographic regions. A better understanding of the seroprevalence of this disease, and the risk factors associated with seropositive status, supply data for the development of screening programs and provide insig...

Descripción completa

Detalles Bibliográficos
Autores principales: Hepburn, Matthew J, Lawitz, Eric J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539356/
https://www.ncbi.nlm.nih.gov/pubmed/15596018
http://dx.doi.org/10.1186/1471-230X-4-31
_version_ 1782122088071430144
author Hepburn, Matthew J
Lawitz, Eric J
author_facet Hepburn, Matthew J
Lawitz, Eric J
author_sort Hepburn, Matthew J
collection PubMed
description BACKGROUND: The seroprevalence of hepatitis C varies substantially between countries and geographic regions. A better understanding of the seroprevalence of this disease, and the risk factors associated with seropositive status, supply data for the development of screening programs and provide insight into the transmission of the disease. The purpose of this investigation was to determine the seroprevalence of hepatitis C and associated risk factors in an urban population in Haiti. METHODS: A prospective survey for hepatitis C antibodies was conducted among an urban outpatient population in Cap-Haïtien, Haiti, with a sample size of 500 subjects. An anonymous 12 question survey, with inquiries related to demographic characteristics and risk factors for HCV acquisition, was concomitantly administered with testing. These demographic and behavioral risk factors were correlated with HCV antibody status using univariate and multivariate tests. RESULTS: The prevalence of positive HCV antibody was 22/500 (4.4%). Subjects that were anti-HCV positive had an average of 7 ± 8.6 lifetime sexual partners, compared to average of 2.5 ± 3.5 lifetime sexual partners among HCV-negative subjects (p = 0.02). In a multiple logistic regression model, intravenous drug use (OR 3.7, 1.52–9.03 95% CI) and number of sexual partners (OR 1.1, 1.04–1.20 95% CI) were independently associated with a positive HCV antibody result. CONCLUSIONS: A substantial number of subjects with HCV antibodies were detected in this population in Haiti. Further investigation into the correlation between the number of sexual partners and testing positive for hepatitis C antibodies is indicated.
format Text
id pubmed-539356
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5393562005-01-01 Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti Hepburn, Matthew J Lawitz, Eric J BMC Gastroenterol Research Article BACKGROUND: The seroprevalence of hepatitis C varies substantially between countries and geographic regions. A better understanding of the seroprevalence of this disease, and the risk factors associated with seropositive status, supply data for the development of screening programs and provide insight into the transmission of the disease. The purpose of this investigation was to determine the seroprevalence of hepatitis C and associated risk factors in an urban population in Haiti. METHODS: A prospective survey for hepatitis C antibodies was conducted among an urban outpatient population in Cap-Haïtien, Haiti, with a sample size of 500 subjects. An anonymous 12 question survey, with inquiries related to demographic characteristics and risk factors for HCV acquisition, was concomitantly administered with testing. These demographic and behavioral risk factors were correlated with HCV antibody status using univariate and multivariate tests. RESULTS: The prevalence of positive HCV antibody was 22/500 (4.4%). Subjects that were anti-HCV positive had an average of 7 ± 8.6 lifetime sexual partners, compared to average of 2.5 ± 3.5 lifetime sexual partners among HCV-negative subjects (p = 0.02). In a multiple logistic regression model, intravenous drug use (OR 3.7, 1.52–9.03 95% CI) and number of sexual partners (OR 1.1, 1.04–1.20 95% CI) were independently associated with a positive HCV antibody result. CONCLUSIONS: A substantial number of subjects with HCV antibodies were detected in this population in Haiti. Further investigation into the correlation between the number of sexual partners and testing positive for hepatitis C antibodies is indicated. BioMed Central 2004-12-14 /pmc/articles/PMC539356/ /pubmed/15596018 http://dx.doi.org/10.1186/1471-230X-4-31 Text en Copyright © 2004 Hepburn and Lawitz; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hepburn, Matthew J
Lawitz, Eric J
Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti
title Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti
title_full Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti
title_fullStr Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti
title_full_unstemmed Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti
title_short Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti
title_sort seroprevalence of hepatitis c and associated risk factors among an urban population in haiti
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539356/
https://www.ncbi.nlm.nih.gov/pubmed/15596018
http://dx.doi.org/10.1186/1471-230X-4-31
work_keys_str_mv AT hepburnmatthewj seroprevalenceofhepatitiscandassociatedriskfactorsamonganurbanpopulationinhaiti
AT lawitzericj seroprevalenceofhepatitiscandassociatedriskfactorsamonganurbanpopulationinhaiti